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deletions in multidrug-resistant
Acinetobacter baumannii
Ismawati Mohammad Amin1, Grace E Richmond3, Paromita Sen1, Tse Hsien Koh2, Laura JV Piddock3
and Kim Lee Chua1*Abstract
Background: Acinetobacter baumannii is an important nosocomial pathogen that has become increasingly resistant
to multiple antibiotics. Genetic manipulation of MDR A. baumannii is useful especially for defining the contribution
of each active efflux mechanism in multidrug resistance. Existing methods rely on the use of an antibiotic selection
marker and are not suited for multiple gene deletions.
Results: A tellurite-resistant (sacB+, xylE+) suicide vector, pMo130-TelR, was created for deleting the adeFGH and
adeIJK operons in two clinical MDR A. baumannii, DB and R2 from Singapore. Using a two-step selection, plasmid
insertion recombinants (first-crossover) were selected for tellurite resistance and the deletion mutants (second-
crossover) were then selected for loss of sacB. The DNA deletions were verified by PCR while loss of gene
expression in the ΔadeFGH, ΔadeIJK and ΔadeFGHΔadeIJK deletion mutants was confirmed using qRT-PCR. The
contribution of AdeFGH and AdeIJK pumps to MDR was defined by comparing antimicrobial susceptibilities of
the isogenic mutants and the parental strains. The deletion of adeIJK produced no more than eight-fold increase
in susceptibility to nalidixic acid, tetracycline, minocycline, tigecycline, clindamycin, trimethoprim and
chloramphenicol, while the deletion of adeL-adeFGH operon alone had no impact on antimicrobial susceptibility.
Dye accumulation assays using H33342 revealed increased dye retention in all deletion mutants, except for the
R2ΔadeFGH mutant, where a decrease was observed. Increased accumulation of ethidium bromide was observed
in the parental strains and all pump deletion mutants in the presence of efflux inhibitors. The efflux pump
deletion mutants in this study revealed that only the AdeIJK, but not the AdeFGH RND pump, contributes to
antimicrobial resistance and dye accumulation in MDR A. baumannii DB and R2.
Conclusions: The marker-less gene deletion method using pMo130-TelR is applicable for creating single and multiple
gene deletions in MDR A. baumannii. The adeFGH and adeIJK operons were successfully deleted separately and
together using this method and the impact of each efflux pump on antimicrobial resistance could be defined clearly.
Keywords: Acinetobacter baumannii, Multidrug-resistant, AdeFGH, AdeIJK, RND pumps, Allelic replacementBackground
Acinetobacter baumannii, a non-fementing Gram-
negative cocco-bacillus, is a frequent cause of nosoco-
mial bloodstream infections and is associated with
considerable morbidity and mortality, especially among
patients in intensive care or with burns [1]. A.
baumannii has become increasingly resistant to multiple* Correspondence: bchckl@nus.edu.sg
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Commons Attribution License (http://creativec
reproduction in any medium, provided the orantibiotics, including imipenem and meropenem, the
carbapenems of choice for treating multidrug resistant
(MDR) A. baumannii infections. The incidence of
carbapenem-resistant A. baumannii in the United States
and Europe is around 54% and 16%, respectively, while
the incidence in the Asia/Pacific rim is about 80% [2]. A.
baumannii possesses a variety of intrinsic and acquired
resistance determinants, including β-lactamases, class D
oxacillinases, aminoglycoside-modifying enzymes, outer
membrane proteins and active efflux systems [3]. Among
its intrinsic resistance determinants, overexpression oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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resistance-nodulation and division (RND) family, such as
AdeABC, AdeFGH and AdeIJK pumps, are a mechanism
of resistance to a number of antibiotics [4].
The impact of RND pumps to antibiotic resistance in
A. baumannii has been demonstrated by inactivating the
genes that encode the efflux pumps and the method for
gene inactivation involves insertion of an antibiotic re-
sistance gene to select mutants [5-7]. Studies using mu-
tants in which RND efflux pump genes have been
inactivated have suggested significant overlap in antibi-
otics that are substrates of the A. baumannii pumps. For
instance, derivatives of the MDR clinical isolate BM4454
in which adeABC was inactivated had increased suscep-
tibility to the same antibiotics (fluoroquinolones, chlor-
amphenicol, tetracycline, tigecycline and erythromycin)
as inactivation of adeIJK in the same isolate [6]. When
both adeABC and adeIJK were inactivated in BM4454,
increased susceptibility to ticarcillin, previously not ob-
served in the ΔadeABC mutant or the ΔadeIJK mutant,
was seen [6]. Furthermore, overexpression of a pump
gene did not always result in an increase in the MIC of
the same antibiotics that had increased activity in the
pump inactivated mutants. For example, inactivation of
adeABC in the MDR clinical isolate BM4454 did not
affect its susceptibility to imipenem, amikacin and
cotrimoxazole, but overexpressing adeABC in a non-
MDR clinical isolate BM4587 increased the MIC of these
antibiotics [4]. Therefore, it is possible that inactivation
of a gene by inserting an antibiotic-resistance gene may
affect the antimicrobial susceptibility of the pump gene-
inactivated mutants, thus complicating the interpretation
of the results.
To address this possibility and to define clearly the im-
pact of each efflux pump on antibiotic resistance, we
propose that genes encoding efflux pumps be deleted
using a marker-less strategy first described by Hamad et
al (2009) for Burkholderia spp. [8]. The suicide vector,
pMo130 was modified to carry a tellurite resistance cas-
sette, a non-antibiotic selection marker [9]. The A.
baumannii isolates we have tested, including MDR iso-
lates, were sensitive to tellurite and can be counter-
selected in LB medium containing 30-60 mg/L tellurite.
Gene deletion by allelic replacement was selected using
a modification of the two-step process described by
Hamad et al (2009) [8]. In this study, the adeFGH and
adeIJK operons were deleted separately and together in
two MDR A. baumannii strains, DB and R2. The adeIJK
deletion mutant showed increased susceptibility to nali-
dixic acid, chloramphenicol, trimethoprim, tetracycline,
tigecycline, minocycline and clindamycin, but the dele-
tion of adeL-adeFGH operon had no impact on anti-
microbial susceptibility in the two MDR isolates.
Genetic and gene expression analyses revealed that theallelic replacement in both MDR strains had occurred.
The marker-less gene deletion method we describe is ro-
bust and, unlike the creation of mutants by inserting an
antibiotic resistance gene, is suitable for deleting mul-
tiple genes in MDR A. baumannii.
Results
Deletion of the A. baumannii adeFGH and adeIJK operons
To ensure reproducibility of the method, gene deletions
were created for the adeFGH and adeIJK operons, separ-
ately and together, in two clinical MDR A. baumannii
isolates, DB and R2. A suicide vector harboring a
tellurite-resistance marker was first created by inserting
a 3.26 kb XmaI-digested tellurite-resistance cassette
from pwFRT-TelR into the XmaI site of pMo130 to give
pMo130-TelR [8,10]. In addition to the tellurite-resistance
marker, pMo130-TelR also carries a kanamycin-resistance
marker, the reporter gene xylE which converts pyroca-
thechol to a yellow-colored 2-hydroxymuconic semial-
dehyde, and a modified sacB gene [8]. Next, DNA
fragments of approximately 1 kb upstream and 1 kb
downstream of the target region to be deleted was liga-
ted with linearized pMo130-TelR give pMo130-TelR-
(Up/Down) (Figure 1A).
To construct the suicide plasmid for deletion of
adeFGH, a 1 kb DNA fragment located upstream of
adeF was amplified from R2 genomic DNA using the
primer pair: AdeGUp(Not1)F and AdeGUp(BamHI)R
(Figure 1B). The amplimer was digested using Not1 and
BamHI and inserted into pMo130-TelR, creating
pMo130-TelR-adeFGH(UP). Next, another 1 kb fragment
located downstream of adeG was amplified using the
primer pair: AdeGDwn(BamHI)F and AdeGDwn(Sph1)R
and cut with BamHI and SphI, and inserted into
pMo130-TelR-adeFGH(Up), thus creating pMo130-TelR-
adeFGH(Up/Down) (Figure 1B). The plasmid construct
was first introduced in E. coli S17-1 and subsequently
delivered into A. baumannii R2 and DB by biparental
conjugation. A. baumannii transconjugants (first cross-
overs) were selected on LB agar containing 30 mg/L
tellurite and 25 mg/L gentamicin. These tellurite-
resistant colonies which carry genomic insertion of
pMo130-TelR-adeFGH (Up/Down) produced yellow col-
onies when sprayed with 0.45 M pyrocathechol and a
2 kb amplimer corresponding to the size of the ligated
Up and Down DNA fragments with the primer pair:
AdeGUp(Not1)F and AdeGDwn(Sph1)R, but did not
produce any amplimer with the outward-facing primer
pair: pMo130Tel F and pMo130Tel R (Figure 1A) (data
not shown). A. baumannii R2 and DB harboring the
inserted pMo130-TelR-adeFGH (Up/Down) construct was
cultured in LB broth containing 10% sucrose and passaged
daily to select for deletion of adeFGH operon and loss
of the sacB gene by a second cross-over and allelic
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Figure 1 (See legend on next page.)
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Figure 1 Strategy for deleting adeL-adeFGH and adeIJK operons in MDR A. baumannii DB and R2. Panel A, The upstream (UP) and
downstream (DOWN) regions (approximately 1 kb) flanking the target genes was cloned into the suicide vector, pMo130-TelR. pMo130-TelR was
constructed by inserting a 3.26 kb XmaI-digested tellurite-resistance cassette from pwFRT-TelR into the XmaI site of pMo130. Recombinants
obtained after first cross-over were selected for inheritance of tellurite-resistance and xylE+ (yellow colonies). These recombinants also do not
produce any amplimers with the primer pair pMo130Tel F and pMo130Tel R. During the second cross-over, mutants with gene deletion (1) were
selected for loss of sacB by passaging the first cross-over recombinants in media containing sucrose. The second cross-over could also yield
parental genotype (2). Deletion of the adeFGH operon (Panel B) and the adeIJK operon (Panel C) showing the positions of the respective UP and
DOWN fragments flanking each deletion (striped and hatched boxes, respectively). The locations of the PCR primers used for amplifying the UP
and DOWN fragments and for qRT-PCR analysis of gene expression are indicated by black arrows while P1, P2 and P3 (grey arrows) are the
locations of predicted promoters for adeFGH operon, adeL, and adeIJK operon, respectively.
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sprayed with 0.45 M pyrocathechol and were susceptible
to 30 mg/L tellurite, usually appeared after the second
passage. If the desired gene deletion had occurred, PCR
of genomic DNA from these bacteria would produce only
a 2 kb amplimer with the primer pair AdeGUp(Not1)F
and AdeGDwn(Sph1)R. The same genomic DNA would
not give any amplimer using the primer pair: AdeG RTF
and AdeG RTR which annealed to the DNA that has been
deleted (Figure 1B).
The suicide plasmid for deleting the adeIJK operon
was constructed as described above but by first ligating
the 1 kb UP fragment and a 0.9 kb DOWN fragment
flanking the deletion before inserting into the pMo130-
TelR vector (Figure 1C). The UP and DOWN fragments
were amplified from R2 genomic DNA using the primer
pairs, AdeJ(UP) PstI F and AdeJ(UP)BamHI R, and AdeJ
(DWN)BamHI F and AdeJ(DWN)SphI R, respectively
(Figure 1C and Additional file 1: Table S1). The UP and
DOWN fragments were digested with BamHI and li-
gated together in a 1:1 ratio. The ligated product was
amplified using AdeJ(UP) PstI and AdeJ(DWN)SphI R to
give a 1.9 kb amplimer which was then digested with
PstI and SphI and ligated with pMo130-TelR linearized
with PstI and SphI to give pMo130-TelR-adeJ(Up/Down).
The plasmid construct was introduced into E. coli S17-1
and used for the two-step selection for deletion of the
adeIJK operon as described above.
Verification of genomic deletions
Genomic deletions of the adeFGH and adeIJK operons
in the mutants were verified by comparing the PCR
amplimers obtained from the parental isolates and corre-
sponding pump gene deletion mutants. For the pump
gene deletions, PCR using primers flanking the deletion
produced a 2-kb amplimer corresponding to the UP and
DOWN fragments (Figure 2, lanes 3, 7, 11, 15, 17, 19, 21
and 23) while a larger wild-type amplimer was obtained
using genomic DNA from the parental isolates, R2 and
DB (Figure 2, lanes 1, 5, 9 and 13). For the ΔadeFGH
constructs, the deletion was also confirmed using PCR
primers that annealed to the deleted region in adeG,whereby a 474 bp amplimer was obtained using genomic
DNA from parental isolates (Figure 2, lanes 2 and 6),
but no amplimer was obtained using genomic DNA
from the ΔadeFGH deletion mutants (Figure 2, lanes 4,
8, 18 and 22). For the ΔadeIJK constructs, the deletion
produced a 0.26-kb amplimer using the primers AdeJ F
and AdeK R and genomic DNA from the ΔadeIJK mu-
tants (Figure 2, lanes 12, 16, 20 and 24) and a longer
3.7-kb amplimer with genomic DNA from the wild-type
parental isolates (Figure 2, lanes 10 and 14).
Transcriptional analysis of the ΔadeFGH and ΔadeIJK
deletion mutants
RNA was extracted from parental strains and pump mu-
tants cultured during mid-logarithmic growth in the ab-
sence of antibiotics. Analysis of the transcripts of the
three major RND pumps in A. baumannii showed that
the expression pattern of adeB, adeG and adeJ genes in
both DB and R2 was similar (Figure 3). In the absence of
any antibiotics, adeIJK was the most highly expressed
pump while the expression of adeFGH was the lowest.
All three pumps were also about 4-fold more highly
expressed in DB as compared to R2 (Figure 3).
To confirm that the gene deletions had abolished the
expression of the efflux pumps, the levels of transcripts
of each gene in the adeFGH and adeIJK operons were
measured in the deletion mutants and compared with
the corresponding transcript levels in the parental
strains. Both the DBΔadeFGH and R2ΔadeFGH mutants
showed significant reduction (to ≤10%) in the transcript
levels for adeF, adeG and adeH when compared to the
parental strains (Figure 4A). Although detectable, the
level of adeL transcription in these mutants was also sig-
nificantly reduced when compared to the adeL tran-
scripts in the parental strains. This was because the
genomic deletion had included the putative adeL pro-
moter. Inactivation of adeG in both DBΔadeFGH and
R2ΔadeFGH mutants was confirmed by the almost un-
detectable levels of adeG transcripts (Figure 4A).
Successful inactivation of adeJ was also similarly con-
firmed by the absence of adeJ transcripts in the
DBΔadeIJK and R2ΔadeIJK mutants (Figure 4B). A small
M 1 2 3 4 5 6 7 8  M 9 10 11 12 13 14 15 16 17 18 19 20     21    22   23    24
1000
3000
6000
500
250
2000
Figure 2 Verification of genomic deletions by PCR of genomic DNA. Amplimers using AdeGUp (NotI)F and AdeGDwn(SphI)R for DB (lane 1)
and DBΔadeFGH (lane 3) DNA; amplimers using AdeG RTF and AdeG RTR for DB (lane 2) and DBΔadeFGH (lane 4) DNA; amplimers using AdeGUp
(NotI)F and AdeGDwn(SphI)R for R2 (lane 5) and R2ΔadeFGH (lane 7) DNA; amplimers using AdeG RTF and AdeG RTR for R2 (lane 6) and
R2ΔadeFGH (lane 8) DNA; amplimers using AdeJ(UP) PstI F and AdeJ(DWN) SphI R for R2 (lane 9), R2ΔadeIJK (lane 11), DB (lane 13) and
DBΔadeIJK (lane 15); amplimers using AdeJ F and AdeK R for R2 (lane 10), R2ΔadeIJK (lane 12), DB (lane 14) and DBΔadeIJK (lane 16);
DBΔadeFGHΔadeIJK DNA amplified using AdeGUp (NotI)F and AdeGDwn(SphI)R (lane 17), AdeG RTF and AdeG RTR (lane 18); AdeJ(UP) PstI F
and AdeJ(DWN) SphI R (lane 19) and AdeJ F and AdeK R (lane 20); R2ΔadeFGHΔadeIJK DNA amplified with AdeGUp (NotI)F and AdeGDwn
(SphI)R (lane 21), AdeG RTF and AdeG RTR (lane 22), AdeJ(UP) PstI F and AdeJ(DWN) SphI R (lane 23) and AdeJ F and AdeK R (lane 24); M,
1 kb DNA ladder (GeneRuler™).
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http://www.biomedcentral.com/1471-2180/13/158quantity of adeI transcripts was udetectable in
DBΔadeIJK and R2ΔadeIJK mutants, albeit at 56% and
31% of wild-type levels, respectively. This was due to the
location of the adeI qRT-PCR primers within the UP
fragment, i.e. within the 5’ undeleted portion of the adeI
gene (Figure 1C).
Next, we tested the feasibility of our marker-less deletion
strategy for creating isogenic mutants carrying a combin-
ation of pump gene deletions. We applied this strategy to
delete adeIJK in the DBΔadeFGH and R2ΔadeFGH mutants
to create DBΔadeFGHΔadeIJK and R2ΔadeFGHΔadeIJK
mutants, respectively. As expected, the DBΔadeFGHΔ-
adeIJK and R2ΔadeFGHΔadeIJK mutants showed signifi-
cantly reduced expression of adeL, adeF, adeG, adeH, adeJ1,189
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Figure 3 Relative expression of adeB, adeG and adeJ in DB and
R2 during mid-log phase. RNA was extracted from mid-log phase
bacteria (OD600 = 1.0) cultured in LB medium. The numbers of adeB,
adeG and adeJ transcripts were each normalized to 16S rRNA
transcripts. Black bars, DB; Light grey bars, R2.and adeK (Figure 4C). Expression of adeI in DBΔadeFGHΔ-
adeIJK and R2ΔadeFGHΔadeIJK mutants was reduced to
38% and 58% of DB and R2 levels, respectively.
Antimicrobial susceptibility profiles of pump deletion
mutants
The parental isolates, DB and R2, were MDR including to
quinolones (nalidixic acid), fluoroquinolones (ciprofloxa-
cin), chloramphenicol, tetracycline, carbapenems (merope-
nem and imipenem), β-lactams (piperacillin, oxacillin),
cephalosporins (ceftazidime), macrolides (erythromycin),
lincosamides (clindamycin), trimethoprim and aminogly-
cosides (gentamicin and kanamycin) (Table 1). Inactiva-
tion of the adeIJK in isolates DB and R2 resulted in at least
a 4-fold increased susceptibility to nalidixic acid, chloram-
phenicol, clindamycin, tetracycline, minocycline and
tigecycline, but had no effect on antimicrobial susceptibil-
ity to β-lactams (oxacillin and piperacillin), cephalosporins
(ceftazidime), fluoroquinolones (ciprofloxacin), carbape-
nems (meropenem and imipenem), erythromycin and
aminoglycosides (gentamicin and kanamycin). DBΔadeIJK
and R2ΔadeIJK mutants were also 8-fold more susceptible
to trimethoprim when compared to the parental isolates.
Although adeL and the adeFGH operon were expressed
in DB and R2, albeit at a lower level that adeB and adeJ,
inactivation of adeFGH in both DB and R2 had minimal
impact on the MDR phenotype of DB and R2 (Table 1).
This is shown by the minimal change in antimicrobial sus-
ceptibility between the mutants that had only adeFGH
inactivated (DBΔadeFGH and R2ΔadeFGH) and both
adeFGH and adeIJK operons inactivated (DBΔadeFGH-
ΔadeIJK and R2ΔadeFGHΔadeIJK) (Table 1). The
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Figure 4 Comparison of adeL-adeFGH operon and adeIJK operon expression in DB and R2 deletion mutants and parental strains. Panel
A, Fold-change in adeL, adeF, adeG and adeH expression in DB versus DBΔadeFGH, R2 versus R2ΔadeFGH; Black bars, DB; grey bars, R2; vertical
stripes, DBΔadeFGH; white bars, R2ΔadeFGH. Panel B, Fold-change in adeI, adeJ and adeK expression in DB versus DBΔadeIJK, and R2 versus
R2ΔadeIJK; Black bars, DB; grey bars, R2; horizontal stripes, DBΔadeIJK; white bars, R2ΔadeIJK. Panel C, Fold-change in adeL, adeF, adeG, adeH,
adeI, adeJ and adeK expression in DB versus DBΔadeFGHΔadeIJK, and R2 versus R2ΔadeFGHΔadeIJK. Black bars, DB; grey bars, R2; horizontal
stripes, DBΔadeFGHΔadeIJK; white bars, R2ΔadeFGHΔadeIJK. All differences in fold-change in gene expression between the parental strains and
deletion mutants were significant (*, p < 0.05; **, p < 0.01).
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Table 1 Antimicrobial susceptibility of MDR A. baumannii DB, R2 and pump deletion mutants
Antibiotic DB DBΔadeFGH DBΔadeIJK DBΔadeFGH ΔadeIJK R2 R2ΔadeFGH R2ΔadeIJK R2ΔadeFGH ΔadeIJK
Nalidixic acid 512 512 128 128 1024 1024 256 256
Ciprofloxacin 64 64 64 64 128 128 128 128
Chloramphenicol 64 64 16 16 128 128 32 32
Tetracycline 512 512 128 128 512 512 128 128
Minocycline 2 2 0.25 0.25 2 2 0.5 0.5
Tigecycline 1 1 0.25 0.25 1 1 0.25 0.25
Meropenem 128 128 128 128 64 64 64 64
Imipenem 32 32 32 32 64 64 64 64
Piperacillin 512 512 512 512 256 256 256 256
Oxacillin > 1024 >1024 > 1024 >1024 1024 1024 1024 1024
Ceftazidime 256 128 256 256 256 128 512 512
Erythromycin 512 512 512 512 512 512 512 512
Clindamycin 128 128 16 16 128 128 16 16
Trimethoprim 128 128 16 16 128 128 16 16
Gentamicin >1024 >1024 >1024 >1024 >1024 >1024 >1024 >1024
Kanamycin >1024 >1024 >1024 >1024 >1024 >1024 >1024 >1024
MIC (mg/L).
Changes in MIC that are ≥ 4-fold are highlighted in bold.
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had the same antimicrobial susceptibility as DBΔadeIJK
and R2ΔadeIJK mutants, respectively (Table 1).
Growth of pump deletion mutants
The optical density at 600 nm measurements of liquid
cultures of the parental strains and pump deletion mu-
tants revealed no significant difference in growth kinet-
ics (data not shown). Growth kinetics in the presence of
sub-MIC concentrations of EIs were also carried out to
simulate conditions in the H33342 accumulation assay
(see below) and to ensure no inhibition of growth over a
two-hour time period during the assay. These experi-
ments showed that 30 mg/L CCCP and 50 mg/L PAβN
did not restrict growth of R2 (data not shown). Viability
of all strains was unaffected by H33342 concentrations
of 2.5 μM, 5 μM and 10 μM (data not shown).
Accumulation of H33342 by efflux pump gene deletion
mutants
Compared with the parental isolate, R2, there was a sig-
nificant 0.8 fold change in the level of H33342 accu-
mulated at steady state in R2ΔadeFGH (Figure 5A).
Compared with the parental isolate, accumulation of
H33342 was significantly increased in R2ΔadeIJK and
R2ΔadeFGHΔadeIJK, with a fold change of 1.18 and
1.16 respectively. The mutants created in isolate DB
showed a different pattern of accumulation (Figure 5B).
The level of H33342 accumulated at steady state was sig-
nificantly higher in all three mutants, DBΔadeFGH,DBΔadeIJK and DBΔadeFGHΔadeIJK, compared with
the parental strain, with fold-changes of 1.13, 1.26 and
1.22, respectively.
Addition of CCCP caused a significant increase in the
steady state accumulation of H33342 by all strains
(Table 2). In the R2 isolate and mutants, this increase
was most pronounced in R2ΔadeFGH, with a fold in-
crease of 1.46 observed (Table 2). The parental isolate
showed a smaller fold increase of 1.31. R2ΔadeIJK and
R2ΔadeFGHΔadeIJK showed the smallest fold changes
of 1.09 and 1.10, respectively. In the DB parent and mu-
tant strain, the parental strain DB showed the highest
fold increase of 1.51 after addition of CCCP, with the in-
crease in DBΔadeFGH slightly less, at 1.27 (Table 2).
DBΔadeIJK and DBΔadeFGHΔadeIJK again showed the
smallest fold changes of 1.16 and 1.19, respectively.
Addition of PAβN also caused a significant increase in
accumulation in all strains (Table 2). This increase was
of a similar fold in the parental strains, R2 and DB, and
their mutants.
Accumulation of ethidium bromide by efflux pump gene
deletion mutants
It has been shown previously that H33342 and ethidium
bromide are substrates of efflux pumps [11]. Therefore,
accumulation of ethidium bromide was also measured.
Compared with the parental isolate, the fold-change in
the steady state levels of ethidium bromide accumulated
in efflux pump mutants showed the same pattern as that
produced with the H33342 accumulation assay, with
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Figure 5 Fold-change in fluorescence of H33342 at steady state levels of accumulation in efflux pump gene deletion mutants
compared with the parental isolate. Three separate experiments showed consistent results and the average fold change is shown. The
standard deviation represents variation between three replicates of the assay. Asterisks indicate significant differences (P ≤ 0.05) in accumulation
compared with the parental strain. Panel A, R2 and mutants. Panel B, DB and mutants.
Amin et al. BMC Microbiology 2013, 13:158 Page 8 of 14
http://www.biomedcentral.com/1471-2180/13/158levels in R2ΔadeFGH significantly lower than in pa-
rental isolate R2 (Figure 6A), and R2ΔadeIJK and
R2ΔadeFGHΔadeIJK accumulating significantly higher
levels. Efflux pump mutants DBΔadeFGH, DBΔadeIJK
and DBΔadeFGHΔadeIJK accumulated higher levels of
ethidium bromide than the parental isolate, DB (Figure 6C).
Addition of both CCCP and PAβN produced a signifi-
cant increase in the level of ethidium bromide accu-
mulated at steady state in both parental isolates and
their mutants and the effect was similar to that seen
with H33342.Table 2 Fold-change in fluorescence of H33342 at steady
state level accumulation in the presence of EIs in efflux
pump mutants and parental strains
Bacterial strain +CCCPa +PAβNb
DB 1.51 ± 0.04 1.29 ± 0.11
DBΔadeFGH 1.27 ± 0.12 1.28 ± 0.03
DBΔadeIJK 1.16 ± 0.06 1.24 ± 0.13
DBΔadeFGHΔadeIJK 1.19 ± 0.03 1.36 ± 0.07
R2 1.31 ± 0.12 1.27 ± 0.04
R2ΔadeFGH 1.46 ± 0.04 1.29 ± 0.03
R2ΔadeIJK 1.09 ± 0.01 1.29 ± 0.05
R2ΔadeFGHΔadeIJK 1.10 ± 0.01 1.20 ± 0.10
Three separate experiments showed consistent results and representative
examples are shown. The standard deviation represents variation between
three biological replicates. All values shown are significant differences
(P ≤ 0.05) in accumulation with addition of an EI relative to absence of EI.
a fold-change compared to corresponding bacterial sample in the absence
of CCCP.
b fold-change compared to corresponding bacterial sample in the absence
of PAβN.Discussion
The two-step deletion strategy we have described was
used for creating unmarked deletions in the adeFGH
and adeIJK efflux pump operons, separately and to-
gether, in two clinical MDR A. baumannii isolates. It is
an improvement from the simple method for gene re-
placement in A. baumannii described by Aranda et al
(2010) that uses an antibiotic resistance cassette [12]. To
adapt the method first described for use in MDR A.
baumannii, we introduced a tellurite resistance cassette
into the pMo130 suicide vector created by Hamad et al
(2009) to facilitate the selection of MDR A. baumannii
transconjugants with the suicide plasmid inserted into
the genome, i.e. first crossover products [8]. It was help-
ful to first ascertain the growth inhibitory concentration
of tellurite for the parental A. baumannii strain so the
number of transconjugants (first crossover) that are false
positives can be minimized by using a suitable tellurite
concentration. Passaging the first crossover recombi-
nants in media containing sucrose provided the selection
pressure for loss of the plasmid by a second crossover,
leading to the formation of white colonies when sprayed
with pyrocathechol.
The main advantage of this method, which does not
use antibiotic selection for the gene deletion mutants, is
its application for generating multiple gene deletions in
a single strain as we have demonstrated by creating
DBΔadeFGHΔadeIJK and R2ΔadeFGHΔadeIJK mutants.
This is particularly important because the majority of A.
baumannii strains are MDR or extensively drug-
resistant (XDR). Other than the MDR strains described
in this study, we have also tested this method in a
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Figure 6 Fold-change in fluorescence of ethidium bromide at steady state level of accumulation in efflux pump gene deletion mutants
compared with the parental isolate. Three separate experiments showed consistent results and representative examples are shown. Standard
deviation represents variation between biological replicates. Asterisks indicate significant differences (P ≤ 0.05) in accumulation compared with
the parental isolate or with addition of an EI. Panel A, Fold-change in level of ethidium bromide accumulated by R2 and mutants. Panel B, Fold-
change in level of ethidium bromide accumulated by R2 and mutants with addition of EIs. Panel C, Fold-change in level of ethidium bromide
accumulated by DB and mutants. Panel D, Fold-change in level of ethidium bromide accumulated by DB and mutants with addition of EIs. Dark
grey, no EI; light grey, CCCP; white, PAβN.
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http://www.biomedcentral.com/1471-2180/13/158carbapenem-susceptible A. baumannii strain (data not
shown). Un-marked deletion mutants are especially use-
ful for ascertaining the contribution of each efflux pump
to MDR as the presence of antibiotic resistance cassettes
in the mutants may complicate the interpretation of
antimicrobial susceptibility. We believe that the marker-
less method would allow the impact of each efflux sys-
tem on antimicrobial resistance to be clearly defined.
The contribution of efflux pumps to antibiotic resist-
ance in A. baumannii has been demonstrated with mu-
tants created by gene inactivation/deletion or by creating
spontaneous efflux pump overexpressing mutants via se-
lection on antibiotic gradients, but with some inconsisten-
cies in antimicrobial susceptibilities depending on how the
genes were inactivated [5]. For example, inactivation of
adeABC in a clinical MDR isolate by insertion of a
ticarcillin-resistance gene conferred increased susceptibil-
ity to aminoglycosides, β-lactams, fluoroquinolones, chlor-
amphenicol, tetracycline, macrolides and trimethoprim
[7]. However when adeABC was deleted and an apramycin
resistance cassette was inserted in the same MDR isolate,
the ΔadeABC mutant showed increased susceptibility tofluoroquinolones, chloramphenicol, tetracycline, tigecyc-
line and macrolides but no change in susceptibility to
aminoglycosides, trimethoprim and β-lactams [4,6]. We
hypothesized that the antibiotic resistance gene used in
the creation of pump gene mutants complicated the inter-
pretation of antimicrobial susceptibility data and hence
which agents were putative substrates of each A.
baumannii efflux pump.
When adeIJK was inactivated using the marker-less
method, the MDR isolates became more susceptible to
nalidixic acid, chloramphenicol, clindamycin, tetracyc-
line, minocycline, tigecycline and trimethoprim. It is in-
teresting to note that the DBΔadeIJK and R2ΔadeIJK
mutants showed increased susceptibility to nalidixic
acid without affecting susceptibility to ciprofloxacin,
suggesting AdeIJK may be specific for quinolones but
not fluoroquinolones. We also noted that, although the
AdeIJK pump confers increased resistance to exactly the
same antibiotics in both DB and R2, the host genotype
had an influence on the magnitude of resistance to each
antibiotic. The successful creation of adeFGH and
adeIJK gene deletions, separately and together, in two
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http://www.biomedcentral.com/1471-2180/13/158MDR A. baumannii isolates demonstrates the robust-
ness of the method and its application across different
MDR A. baumannii isolates. The antibiotic substrates
revealed with our mutants are in general agreement with
those described by Damier-Piolle et al (2008) in which
adeIJK was inactivated in an MDR isolate by gene dele-
tion together with insertion of a kanamycin-resistance
cassette [6]. However, in our study the DBΔadeIJK and
R2ΔadeIJK mutants were also more susceptible to tri-
methoprim, but not to β-lactams. It should be noted that
differences between these studies may be due to the
presence of different antibiotic resistance genes on the
host genome, e.g. R2 had blaOXA-23 like, blaOXA-51 like
genes, blaTEM, blaOXA and blaADC that confer β-lactam
resistance. The MICs of antibiotics for double mutants
R2ΔadeFGHΔadeIJK and DBΔadeFGHΔadeIJK were
the same as for the corresponding single mutants
R2ΔadeIJK and DBΔadeIJK. This was expected, as a sin-
gle deletion of adeFGH had minimal effect on MICs of
antibiotics in either strain.
Deletion of adeIJK and of adeFGH in combination
with adeIJK in both R2 and DB resulted in a significant
increase in steady state accumulation levels of both
H33342 and ethidium bromide. This infers reduced ef-
flux in these strains, presumably as a consequence of the
removal of the efflux pump AdeIJK. Addition of CCCP
to ΔadeIJK and ΔadeFGHΔadeIJK mutants of both R2
and DB significantly increased the steady state accumu-
lation of H33342, suggesting that, despite lacking
AdeIJK, these mutants still possess proton gradient
dependent efflux activity as a result of another pump
system. The addition of CCCP and PAβN had the same
effect on the accumulation of ethidium bromide. How-
ever, the increase in accumulation observed in these mu-
tants was not as high as that seen with the parental
isolates and the adeFGH deletion mutants, supporting
the previous finding that efflux is reduced in mutants
lacking adeIJK.
In our study, the deletion of the adeFGH operon also
removed the putative adeL promoter, resulting in re-
duced expression of adeL. However, both the inactiva-
tion of the adeFGH operon and reduced expression of
adeL had very little impact on antimicrobial susceptibil-
ity when compared to the parental isolates which
expressed both adeL and adeFGH operon. This was also
true when the antimicrobial susceptibilities of DB and
R2 mutants that had both the adeIJK and adeFGH op-
erons deleted were compared with the DB and R2 mu-
tants that had only the adeIJK operon inactivated. In all
instances, inactivation of adeFGH had minimal impact
on antimicrobial susceptibility when compared to iso-
genic isolates with functional AdeFGH, indicating that
expression of adeL and adeFGH operon was not in-
volved in the multidrug resistance of these clinical MDRisolates. These findings are different to those of Coyne
et al, who showed that overexpressing adeFGH in
an MDR strain lacking AdeABC and AdeIJK increased
the MICs of several antibiotics including chlorampheni-
col, clindamycin, tetracycline, minocycline, tigecycline,
norfloxacin, ciprofloxacin and cotrimoxazole [5]. In that
study, the adeFGH operon was overexpressed in a spon-
taneous drug-resistant ΔadeABCΔadeIJK mutant se-
lected on norfloxacin and chloramphenicol gradient
plates. The adeFGH operon was then deleted and a
streptomycin-spectinomycin resistance cassette was also
inserted to select for the deletion mutant. It is plausible
that the process of selecting spontaneous drug-resistant
mutants on chloramphenicol and norfloxacin gradients
may have created gene duplication and amplification or
a mutation in another efflux pump regulator was se-
lected, especially since the inhibition of DNA gyrase by
fluoroquinolones induces the SOS response [13]. It is
also possible that under the experimental conditions
whereby the adeFGH operon was induced and signifi-
cantly overexpressed, an increase in resistance to chlor-
amphenicol, trimethoprim and clindamycin may be
observed. However, further studies are needed to deter-
mine the significance and relevance of such conditions
to the clinical environment [14]. It was proposed that
mutation in adeL results in overexpression of adeFGH
operon and hence an increase in antibiotic resistance
[5]. It is also possible that mutation in adeL, a LysR-type
transcriptional regulator, may affect expression of an-
other efflux pump gene/s or antibiotic resistance deter-
minant. However, in the DBΔadeFGH and R2ΔadeFGH
mutants created in the present study, adeL expression
was impaired yet there was minimal change in the MICs
of antibiotics for the mutants when compared with the
parental isolates. This ruled out the possibility that the
MDR phenotype of DB and R2 might be due to a muta-
tion in adeL which had an effect on the expression of
another efflux pump(s) other than the adeFGH operon.
Our data suggests that the activities of the AdeL tran-
scriptional regulator and AdeFGH pump do not contrib-
ute to multidrug resistance in DB and R2.
Despite the minimal change in MICs of antibiotics
compared with the parental isolate, R2ΔadeFGH showed
a significant decrease in accumulation of both H33342
and ethidium bromide, inferring increased efflux in this
strain. This may be due to increased expression of an-
other efflux system in order to compensate for the loss
of AdeFGH. This could also explain the lack of change
in MIC seen with deletion of adeFGH. Previous work in
Salmonella enterica serovar Typhimurium has shown
that deletion of RND efflux pump genes can lead to
compensatory altered expression of other efflux pump
genes. For example, deletion of acrB in SL1344 resulted
in a 7.9 fold increase in the expression of acrF [15]. An
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ide was seen in DBΔadeFGH, inferring reduced efflux in
this strain, however this difference did not translate into
a change in MIC. Addition of CCCP and PAβN had a
greater effect on accumulation of H33342 and ethidium
bromide in this efflux pump mutant than in mutants
lacking adeIJK. A greater fold change in accumulation
was seen with both R2ΔadeFGH and DBΔadeFGH than
other efflux pump mutants, suggesting that efflux activ-
ity is higher in these mutants.
Using the marker-less deletion method, we have dem-
onstrated that AdeFGH and AdeIJK are independent ef-
flux pumps with no common antibiotic substrates.
While both adeFGH and adeIJK operons are expressed
in MDR A. baumannii, only the expression of adeIJK
contributed to increased resistance to nalidixic acid,
chloramphenicol, clindamycin, tetracycline, minocycline,
tigecycline and trimethoprim. Expression of adeFGH
was not the cause of resistance in the clinical isolates of
MDR A. baumannii, DB and R2.
Conclusions
The marker-less gene deletion method we have de-
scribed is useful for creating gene deletions in MDR A.
baumannii. Deletions of the adeFGH and adeIJK efflux
pump operons, separately and together, were created in
two clinical MDR A. baumannii isolates to demonstrate
the robustness of the method. Even though both
adeFGH and adeIJK operons are expressed in MDR A.
baumannii, only the expression of adeIJK contributed to
increased resistance to nalidixic acid, chloramphenicol,
clindamycin, tetracycline, minocycline, tigecycline and
trimethoprim. Expression of adeFGH was not the cause
of resistance in the clinical isolates of MDR A.
baumannii, DB and R2. This method allows the impact
of each efflux system on antimicrobial resistance to be
clearly defined.
Methods
Bacterial strains, plasmids and culture conditions
Bacterial strains and plasmids used in this study are
listed in Table 3. Acinetobacter baumannii R2
(TTSH6013 654325/06) and DB (DB15354/07) were
clinical isolates from a collection by the Network
for Antimicrobial Resistance Surveillance, Singapore.
According to the interim standard definitions for
acquired resistance, both DB and R2 are classified as
MDR as they are non-susceptible to ≥1 agent in ≥3 anti-
microbial categories (aminoglycosides, fluoroquinolones,
carbapenems, tetracycline, extended spectrum cephalo-
sporins, folate pathway inhibitors) [17]. DB and R2 carry
and express blaOXA-23-like and blaOXA-51-like, do not carry
blaOXA-24-like and blaOXA-58-like (data not shown). A.
baumannii and E. coli were cultured under aerobicconditions at 37°C in Luria-Bertani Miller (LB) agar or
LB broth (Becton Dickinson, Cockeysville, U.S.A.). Anti-
biotics used were at the following concentrations for E.
coli: kanamycin, 10 mg/L; tellurite 6 mg/L; and for A.
baumannii: tellurite, 30 mg/L.
DNA manipulations
Bacterial genomic DNA was extracted using a rapid pro-
cedure described by Pitcher et al [18]. Plasmid DNA was
extracted using GeneAid Hi-Speed Plasmid Mini kit
(GeneAid, Taiwan). Standard PCR amplifications were
performed with Biotools DNA polymerase (Biotools,
Spain). All primers used for PCR were synthesized by 1st
Base Singapore and are listed in Additional file 1: Table
S1. Electrocompetent cells were prepared from 6 ml
overnight bacterial culture according to the procedure
described by Choi et al (2005) [19]. Electroporation was
carried out by placing 100 μl electrocompetent cells and
3 μl plasmid DNA in a sterile cuvette (0.1 cm electrode
gap, Bio-Rad) and pulsed at 1.8 V using settings for bac-
teria in a Bio-Rad MicroPulser.
The plasmid, pwFRT-TelR, was digested with XmaI and
the 3.265 kb fragment carrying the tellurite-resistance cas-
sette was isolated and ligated with XmaI-linearized
pMo130 to produce the suicide plasmid, pMo130-TelR.
The orientation of the tellurite-resistance cassette insert
shown in Figure 1A was ascertained by digesting the plas-
mid with Xho1 and BamHI which gave a 4.161 kb and a
5.231 kb band. An insertion of the tellurite-resistance cas-
sette into pMo130-TelR in the opposite orientation would
have produced two bands of 1.150 kb and 8.242 kb.
Conjugative transfer
E. coli S17-1 donor strain harboring the respective
pMo130-TelR-(Up/Down) constructs and the A. baumannii
recipient strains were cultured overnight at 37°C in 2 ml
LB (supplemented with kanamycin for the donor E. coli
strain). Aliquots of 0.2 ml each of donor and recipient cells
were added to a microfuge tube containing 1.2 ml of LB
and washed twice with 2 ml LB each time. The cells were
then suspended in 30 μl LB medium and added on to a
sterile 0.45 μm cellulose nitrate filter paper (Sartorius
Stedim, NY, U.S.A.) on LB agar and incubated at 30°C for
16 h. The cells were washed off from the filter by adding
0.4 ml of 0.9% NaCl. Aliquots of 0.1 ml were plated onto
LB agar containing tellurite (30 mg/L) and gentamicin
(25 mg/L) and incubated at 37°C for at least 16 h. Gentami-
cin was added for counter-selection against the donor cells.
RNA analysis and quantitative real-time PCR (qRT-PCR)
RNA was extracted from mid-log phase bacteria pre-
pared by inoculating 10 ml Luria-Bertani (LB) broth
Miller (1st BASE Pte Ltd, Singapore) with an overnight
culture (1:50) and incubating at 37°C, with shaking at
Table 3 List of bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Reference or source
A. baumannii strains
R2 Wild-type clinical MDR isolate TTSH6013 624325/06 Network for Antimicrobial
Resistance Surveillance (Singapore)
DB Wild-type clinical MDR isolate DB15354/07 Network for Antimicrobial
Resistance Surveillance (Singapore)
R2ΔadeFGH R2 with deletion in adeFGH operon This study
R2ΔadeIJK R2 with deletion in adeIJK operon This study
R2ΔadeFGHΔadeIJK R2 with deletion in adeFGH and adeIJK operons This study
DBΔadeFGH DB with deletion in adeFGH operon This study
DBΔadeIJK DB with deletion in adeIJK operon This study
DBΔadeFGHΔadeIJK DB with deletion in adeFGH and adeIJK operons This study
E. coli strains
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17
phoA supE44 λ– thi-1 gyrA96 relA1
Invitrogen
S17-1 Genotype: recA pro hsdR RP4-2-Tc::Mu-Km::Tn7, GmS [16]
Plasmids
pMo130 Suicide plasmid, xylE+, sacB+, KmR [8]
pwFRT-TelR Donor of tellurite resistance cassette [10]
pMo130-TelR pMo130 plasmid containing 3.26 kb XmaI-digested tellurite-
resistance cassette from pwFRT-TelR
This study
pMo130-TelR-P8(UP/DWN) pMo130-TelR containing a 1 kb UP fragment (promoterless adeL)
and 1 kb DOWN fragment (3’ partial adeH)
This study
pMo130-TelR-adeJ(Up/Down) pMo130-TelR containing a 1 kb UP fragment (5’ partial adeI)
and 0.9 kb DOWN fragment (3’ partial adeK)
This study
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umes containing two OD600 units (~ 2x10
9 cells) were
centrifuged at 3,000 g for 10 min to harvest the cells.
The cells were lysed by adding 1 mL of TRIzol®
(Invitrogen, Carlsbad, CA) to the cell pellet and RNA
was extracted according to the manufacturer’s protocol.
Contaminating DNA was removed by treating the RNA
sample with Ambion® TURBO™ DNase (Invitrogen)
and cDNA was synthesized using random hexamer
primers and TaqMan® Reverse Transcription Reagents
(Invitrogen) according to the manufacturer’s protocol.
Primers for qRT-PCR of efflux pumps genes were
designed using PrimerQuest (Integrated DNA Technolo-
gies, Coralville, IA) and are listed in Additional file 1: Table
S2 (Supplementary files). qRT-PCR was performed using
KAPA SYBR® FAST Universal 2X qPCR Master Mix (Kapa
Biosystems Inc., Woburn, MA) using 1X ROX (High) refer-
ence dye, 500 nm primers and ~10 ng cDNA in a total vol-
ume of 20 μL and the transcripts were detected using
Applied Biosystems 7300 Real-Time PCR system (Applied
Biosystems®, Carlsbad, CA). 16S rRNA was used for
normalization of the qRT-PCR gene transcripts. qRT-PCR
was performed twice for each of the triplicate RNA extracts.
Data from each quantitative run was exported from the 7300
System software and analysed using 2-ΔΔCt calculations [20].Antimicrobial susceptibility testing
Minimum inhibitory concentrations (MICs) of antibi-
otics were determined using the agar doubling dilution
method according to BSAC standard methodology [21].
MICs of imipenem and meropenem were determined by
E-test (Biomerieux, Hampshire, UK).
Measurement of growth kinetics
Bacterial strains were grown with aeration in LB broth
at 37°C overnight. Bacterial cultures were diluted 1:100
in sterile Luria Bertani (LB) broth and 100 μl of this sus-
pension was added to each well of a clear 96 well microti-
tre tray. Optical density (OD) at an absorbance of 600 nm
was measured over 16 hours in a BMG FLUOstar Optima
(BMG, UK) at 37°C. The BMG FLUOstar is sensitive to an
OD600 of between 0.0 and 4.0 and reproducibility
is ±0.010 for the OD range of 0.0-2.0 (www.bmglabtech.
com). Each experiment included three biological replicates
and three technical replicates of each bacterial strain.
Differences in generation times and final OD at 600 nm
were calculated using a Student’s t-test. P values ≤0.05
were considered as significant.
For assessment of toxicity of EIs and H33342, bacterial
strains were grown with aeration in LB broth at 37°C
overnight. A 4% inoculum (120 μl in 3 ml) of bacterial
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was incubated with aeration at 37°C until the culture
reached an OD at 600 nm of 0.6 (= 108 cfu/ml). Cells
were harvested by centrifugation at 2200 g for 10 min at
room temperature and resuspended in 3 ml sterile LB
broth at room temperature. The OD at 600 nm of the
suspension was measured and adjusted to 0.5 to
standardize the number of bacterial cells in each culture
and to simulate the conditions used in the H33342 accu-
mulation assay. The bacterial suspension (196 μl) was
added to each well of a clear 96 well microtitre tray, along
with 4 μl of EI and 20 μl H33342 at the required concentra-
tions (see Results). OD at an absorbance of 600 nm
was measured over 16 hours in the BMG FLUOstar
OPTIMA (BMG, UK) at 37°C. Each experiment in-
cluded three biological replicates and three technical repli-
cates of each bacterial strain. Differences in generation
times and final OD at 600 nm were calculated using a Stu-
dent’s t-test. P values ≤0.05 were considered as significant.
H33342 bis-benzamide accumulation in efflux pump
deletion mutants
Accumulation of H33342 was measured and data
analysed as described previously [11]. The level at which
maximum fluorescence was reached and remained un-
changed within the time period of the assay was taken
as the steady state accumulation level. The fold change
in fluorescence of mutants compared to the parental
clinical isolate in the presence and absence of efflux
pump inhibitors (EI) was calculated. Student’s t-tests
were carried out to compare the accumulation of
H33342 by the mutant with the parental strain, R2;
P values <0.05 were taken as significant. Each assay was
repeated 3 times with 3 biological replicates.
Ethidium bromide accumulation in efflux pump deletion
mutants
Ethidium bromide assays were carried out in the same way
as the H33342 accumulation assay, except that cultures
were resuspended in 1 M sodium phosphate buffer with 5%
glucose. A 1 mM ethidium bromide stock solution was pre-
pared and 20 μl was injected to give a final concentration
of 0.1 mM in the assay. Fluorescence was measured over
117 minutes at excitation and emission wavelengths of
530 nm and 600 nm, respectively, in a FLUOstar OPTIMA.
Additional file
Additional file 1: Table S1. Description of primers used for PCR and
DNA sequencing. Table S2. List of primers used for quantitative real-time
PCR.
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